Adverum Biotechnologies to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Adverum Biotechnologies will present at the following upcoming investor conferences:
The on-demand webcast corporate presentation may be accessed under Events and Presentations in the Investors section of Adverum’s website. A replay of the webcast will be aailable on the website for 90 days following the presentation.
About Adverum Biotechnologies
Corporate, Investor and Media Inquiries
Adverum Biotechnologies, Inc.
Meshing Technologies: Managing Wifi and Private 4G/5G with Public Carrier Networks
Making the Future of Work Safe and Secure